Italy
· Delayed Price · Currency is EUR Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of EUR 175.05 billion. The enterprise value is 197.68 billion.
| Market Cap | 175.05B |
| Enterprise Value | 197.68B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | Mar 14, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.30% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 10.85.
| PE Ratio | 10.85 |
| Forward PE | n/a |
| PS Ratio | 2.96 |
| PB Ratio | 3.91 |
| P/TBV Ratio | 17.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.70, with an EV/FCF ratio of 12.54.
| EV / Earnings | 12.26 |
| EV / Sales | 3.51 |
| EV / EBITDA | 7.70 |
| EV / EBIT | 9.19 |
| EV / FCF | 12.54 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.
| Current Ratio | 1.41 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 1.20 |
| Debt / FCF | 2.04 |
| Interest Coverage | 19.06 |
Financial Efficiency
Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.
| Return on Equity (ROE) | 39.29% |
| Return on Assets (ROA) | 13.81% |
| Return on Invested Capital (ROIC) | 19.33% |
| Return on Capital Employed (ROCE) | 27.14% |
| Revenue Per Employee | 799,198 |
| Profits Per Employee | 217,972 |
| Employee Count | 75,000 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.95% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -38.95% |
| 50-Day Moving Average | 79.90 |
| 200-Day Moving Average | 93.91 |
| Relative Strength Index (RSI) | 39.79 |
| Average Volume (20 Days) | 288 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.42 |
Income Statement
In the last 12 months, Merck & Co. had revenue of EUR 59.14 billion and earned 16.13 billion in profits. Earnings per share was 6.36.
| Revenue | 59.14B |
| Gross Profit | 45.58B |
| Operating Income | 22.59B |
| Pretax Income | 18.66B |
| Net Income | 16.13B |
| EBITDA | 26.64B |
| EBIT | 22.59B |
| Earnings Per Share (EPS) | 6.36 |
Balance Sheet
The company has 8.54 billion in cash and 32.24 billion in debt, giving a net cash position of -23.70 billion.
| Cash & Cash Equivalents | 8.54B |
| Total Debt | 32.24B |
| Net Cash | -23.70B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 44.78B |
| Book Value Per Share | 17.77 |
| Working Capital | 9.56B |
Cash Flow
In the last 12 months, operating cash flow was 19.32 billion and capital expenditures -3.55 billion, giving a free cash flow of 15.76 billion.
| Operating Cash Flow | 19.32B |
| Capital Expenditures | -3.55B |
| Free Cash Flow | 15.76B |
| FCF Per Share | n/a |
Margins
Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.
| Gross Margin | 77.07% |
| Operating Margin | 38.19% |
| Pretax Margin | 31.55% |
| Profit Margin | 27.27% |
| EBITDA Margin | 45.05% |
| EBIT Margin | 38.19% |
| FCF Margin | 26.66% |
Dividends & Yields
This stock pays an annual dividend of 2.93, which amounts to a dividend yield of 4.05%.
| Dividend Per Share | 2.93 |
| Dividend Yield | 4.05% |
| Dividend Growth (YoY) | 5.72% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 45.54% |
| Buyback Yield | 0.30% |
| Shareholder Yield | 4.34% |
| Earnings Yield | 9.21% |
| FCF Yield | 9.01% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Merck & Co. has an Altman Z-Score of 4.7.
| Altman Z-Score | 4.7 |
| Piotroski F-Score | n/a |